{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T21:12:42Z","timestamp":1649452362529},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12185-014-1610-2","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T07:22:05Z","timestamp":1403162525000},"page":"402-406","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HIV-related NK\/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity"],"prefix":"10.1007","volume":"100","author":[{"given":"Yosuke","family":"Nagahata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"1610_CR1","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.285.14.1880","volume":"285","author":"RF Little","year":"2001","unstructured":"Little RF, Gutierrez M, Jaffe ES, Pau A, Horne M, Wilson W. HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. JAMA. 2001;285:1880\u20135.","journal-title":"JAMA"},{"key":"1610_CR2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3851\/IMP1462","volume":"14","author":"J Bohlius","year":"2009","unstructured":"Bohlius J, Schmidlin K, Costagliola D, Fatkenheuer G, May M, Caro-Murillo AM, et al. Incidence and risk factors of HIV-related non-Hodgkin\u2019s lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther. 2009;14:1065\u201374.","journal-title":"Antivir Ther."},{"key":"1610_CR3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11912-001-0059-7","volume":"3","author":"DJ Straus","year":"2001","unstructured":"Straus DJ. HIV-associated lymphomas. Curr Oncol Rep. 2001;3:260\u20135.","journal-title":"Curr Oncol Rep."},{"key":"1610_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(03)00957-4","volume":"4","author":"C Antonino","year":"2003","unstructured":"Antonino C. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 2003;4:22\u20139.","journal-title":"Lancet Oncol."},{"key":"1610_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0046-8177(97)90137-4","volume":"28","author":"S Camilleri-Broet","year":"1997","unstructured":"Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P, et al. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French study group for HIV-associated tumors. Hum Pathol. 1997;28:367\u201374.","journal-title":"Hum Pathol"},{"key":"1610_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V82.2.619.619","volume":"82","author":"SJ Hamilton-Dutoit","year":"1993","unstructured":"Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, et al. In situ demonstration of Epstein\u2013Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 1993;82:619\u201324.","journal-title":"Blood"},{"key":"1610_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.1711670406","volume":"167","author":"J Audouin","year":"1992","unstructured":"Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein\u2013Barr virus latent membrane protein-1 in tumour cells of Hodgkin\u2019s disease in HIV-positive patients. J Pathol. 1992;167:381\u20134.","journal-title":"J Pathol."},{"key":"1610_CR8","first-page":"480","volume":"27","author":"F Spina","year":"2000","unstructured":"Spina F, Vaccher E, Nasti G, Tirelli U. Human immunodeficiency virus-associated Hodgkin\u2019s disease. Semin Oncol. 2000;27:480\u20138.","journal-title":"Semin Oncol"},{"key":"1610_CR9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.21947","volume":"86","author":"JJ Castillo","year":"2011","unstructured":"Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, et al. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011;86:256\u201361.","journal-title":"Am J Hematol"},{"key":"1610_CR10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.12341","volume":"161","author":"L Gilardin","year":"2013","unstructured":"Gilardin L, Copie-Bergman C, Galicier L, Meignin V, Briere J, Timsit JF, et al. Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era. Br J Haematol. 2013;161:843\u201351.","journal-title":"Br J Haematol"},{"key":"1610_CR11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.5858\/2001-125-0660-NNKLAW","volume":"125","author":"D Canioni","year":"2001","unstructured":"Canioni D, Arnulf B, Asso-Bonnet M, Raphael M, Brousse N. Nasal natural killer lymphoma associated with Epstein\u2013Barr virus in a patient infected with human immunodeficiency virus. Arch Pathol Lab Med. 2001;125:660\u20132.","journal-title":"Arch Pathol Lab Med"},{"key":"1610_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1532\/IJH97.A10316","volume":"79","author":"SC Oh","year":"2004","unstructured":"Oh SC, Choi CW, Kim BS, Shin SW, Kim YH, Lee JS, et al. NK\/T-cell lymphoma associated with Epstein\u2013Barr virus in a patient infected with human immunodeficiency virus: an autopsy case. Int J Hematol. 2004;79:480\u20133.","journal-title":"Int J Hematol"},{"key":"1610_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jcp.2004.022608","volume":"58","author":"CS Chim","year":"2005","unstructured":"Chim CS, Ma ES, Loong F, Kwong YL. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein\u2013Barr virus encoded early small RNA in detecting occult bone marrow involvement. J Clin Pathol. 2005;58:443\u20135.","journal-title":"J Clin Pathol"},{"key":"1610_CR14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00000478-199910000-00003","volume":"23","author":"Y Kagami","year":"1999","unstructured":"Kagami Y, Suzuki R, Taji H, Yabe Y, Takeuchi T, Maeda S, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999;23:1184\u2013200.","journal-title":"Am J Surg Pathol"},{"key":"1610_CR15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.MP.0000036386.87517.AA","volume":"15","author":"H Saffer","year":"2002","unstructured":"Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ. Clusterin expression in malignant lymphomas: a survey of 266 cases. Mod Pathol. 2002;15:1221\u20136.","journal-title":"Mod Pathol"},{"key":"1610_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2008.02997.x","volume":"52","author":"E Takahashi","year":"2008","unstructured":"Takahashi E, Asano N, Li C, Tanaka T, Shimada K, Shimada S, et al. Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology. 2008;52:585\u201396.","journal-title":"Histopathology"},{"key":"1610_CR17","first-page":"635","volume":"35","author":"M Okamoto","year":"1994","unstructured":"Okamoto M, Maruyama F, Tsuzuki M, Nomura T, Miyazaki H, Wakita M, et al. Salvage chemotherapy for relapsed\/refractory aggressive non-Hodgkin\u2019s lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin. Rinsho Ketsueki. 1994;35:635\u201341.","journal-title":"Rinsho Ketsueki."},{"key":"1610_CR18","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, et al. Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27:5594\u2013600.","journal-title":"J Clin Oncol"},{"key":"1610_CR19","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29:4410\u20136.","journal-title":"J Clin Oncol"},{"key":"1610_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12185-012-1189-4","volume":"96","author":"M Yamaguchi","year":"2012","unstructured":"Yamaguchi M. Current and future management of NK\/T-cell lymphoma based on clinical trials. Int J Hematol. 2012;96:562\u201371.","journal-title":"Int J Hematol"},{"key":"1610_CR21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00001622-199509000-00010","volume":"7","author":"JA Sparano","year":"1995","unstructured":"Sparano JA. Treatment of AIDS-related lymphomas. Curr Opin Oncol. 1995;7:442\u20139.","journal-title":"Curr Opin Oncol"},{"key":"1610_CR22","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","volume":"122","author":"SK Barta","year":"2013","unstructured":"Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013;122:3251\u201362.","journal-title":"Blood"},{"key":"1610_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","volume":"1","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;1:583\u20137.","journal-title":"Lancet"},{"key":"1610_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","volume":"367","author":"S Webber","year":"2006","unstructured":"Webber S, Naftel D, Fricker F, Olesnevich P, Blume E, Addonizio L, et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006;367:233\u20139.","journal-title":"Lancet"},{"key":"1610_CR25","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1182\/blood-2002-01-0210","volume":"100","author":"P Porcu","year":"2002","unstructured":"Porcu P, Eisenbeis CF, Pelletier RP, Davies EA, Baiocchi RA, Roychowdhury S, et al. Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8\u00a0+\u00a0T-cell restoration. Blood. 2002;100:2341\u20138.","journal-title":"Blood"},{"key":"1610_CR26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1993.11.6.1099","volume":"11","author":"JM Pluda","year":"1993","unstructured":"Pluda JM, Vemzon DJ, Tosato G, Lietzau J, Wyvill K, Nelson DL, et al. Parameters affecting the development of non-Hodgkin\u2019s lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol. 1993;11:1099\u2013107.","journal-title":"J Clin Oncol"},{"key":"1610_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcv.2011.12.021","volume":"53","author":"R Tedeschi","year":"2012","unstructured":"Tedeschi R, Bortolin MT, Bidoli E, Zanussi S, Pratesi C, Vaccher E, et al. Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome. J Clin Virol. 2012;53:297\u2013301.","journal-title":"J Clin Virol"},{"key":"1610_CR28","first-page":"952","volume":"12","author":"JP McGowan","year":"1998","unstructured":"McGowan JP, Shah S. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS. 1998;12:952\u20134.","journal-title":"AIDS."},{"key":"1610_CR29","unstructured":"Corales R, Raege A. Regression of AIDS-related CNS lymphoma with HAART. XIII International AIDS Conference, Durban, 2000."},{"key":"1610_CR30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1089\/apc.2007.0009","volume":"21","author":"DM Aboulafia","year":"2007","unstructured":"Aboulafia DM, Puswella AL. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment. AIDS Patient Care STDS. 2007;21:900\u20137.","journal-title":"AIDS Patient Care STDS."},{"key":"1610_CR31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s12185-011-0859-y","volume":"93","author":"YK Teng","year":"2011","unstructured":"Teng YK, Schippers EF, Wijermans PW. Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only. Int J Hematol. 2011;93:811\u20134.","journal-title":"Int J Hematol"},{"key":"1610_CR32","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1200\/JCO.2011.39.9642","volume":"30","author":"G Travi","year":"2012","unstructured":"Travi G, Ferreri AJ, Cinque P, Gerevini S, Ponzoni M, Terreni MR, et al. Long-term remission of HIV-associated primary CNS lymphoma achieved with highly active antiretroviral therapy alone. J Clin Oncol. 2012;30:e119\u201321.","journal-title":"J Clin Oncol"},{"key":"1610_CR33","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R, Socie G, Stoppa AM, Vandenberghe P, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006;107:3053\u20137.","journal-title":"Blood"},{"key":"1610_CR34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1309\/LYXN3RGF7D7KPYG0","volume":"127","author":"SH Swerdlow","year":"2007","unstructured":"Swerdlow SH. T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127:887\u201395.","journal-title":"Am J Clin Pathol"},{"key":"1610_CR35","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322\u201331.","journal-title":"J Rheumatol"},{"key":"1610_CR36","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","volume":"14","author":"E Salloum","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943\u20139.","journal-title":"J Clin Oncol"},{"key":"1610_CR37","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2010-03-274076","volume":"116","author":"K Jones","year":"2010","unstructured":"Jones K, Nourse JP, Morrison L, Nguyen-Van D, Moss DJ, Burrows SR, et al. Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders. Blood. 2010;116:2245\u201352.","journal-title":"Blood"},{"key":"1610_CR38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jcp.2008.062976","volume":"62","author":"Y Isobe","year":"2009","unstructured":"Isobe Y, Aritaka N, Sasaki M, Oshimi K, Sugimoto K. Spontaneous regression of natural killer cell lymphoma. J Clin Pathol. 2009;62:647\u201350.","journal-title":"J Clin Pathol"},{"key":"1610_CR39","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2007-10-115659","volume":"111","author":"M Bower","year":"2008","unstructured":"Bower M, Stebbing J, Tuthill M, Campbell V, Krell J, Holmes P, et al. Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. Blood. 2008;111:3986\u201390.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1610-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1610-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1610-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T20:31:49Z","timestamp":1649449909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1610-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1610"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1610-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]}}}